Abstract
Apolipoprotein E allele 4 (apo ɛ4) and smoking each have been associated with an unfavorable lipid profile. We used data collected on 1,472 subjects in the National Heart, Lung, and Blood Institute Family Heart Study to assess whether smoking interacts with apo ɛ4 to influence the levels of plasma lipids. We dichotomized smoking and apo ɛ4 and used analysis of covariance to estimate the means of lipids. Smokers had lower body mass index, were younger, and consumed less fruits and vegetables. Among individuals without apo ɛ4, comparing nonsmokers with smokers, mean low density lipoprotein cholesterol (LDL) was 129.3 and 134.4 mg/dL, respectively, for women and 126.1 and 127.6 mg/dL, respectively, for men. Among subjects with an apo ɛ4 allele, corresponding means were 132.0, and 152.9 mg/dL, respectively, for women and 131.3 and 137.3 mg/dL, respectively, for men (P for interaction <0.001 for women and 0.11 for men). A similar interaction was observed for total cholesterol among women (P=0.02). This study shows a statistically significant effect modification of the relation of apo ɛ4 to LDL and total cholesterol by smoking among women. Smoking may enhance genetic susceptibility to an unfavorable lipid profile among subjects with apo ɛ4.
Similar content being viewed by others
Abbreviations
- Apo ɛ4 :
-
apolipoprotein E allele ɛ4
- ARIC:
-
Atherosclerosis Risk in Communities
- BMI:
-
body mass index
- CHD:
-
coronary heart disease
- HDL:
-
high density lipoprotein cholesterol
- LDL:
-
low density lipoprotein cholesterol
- Ln:
-
natural logarithm
- NHLBI:
-
National Heart, Lung, and Blood Institute
- PCR:
-
polymerase chain reaction
References
Laakso, M. (1996) Lipids and Lipoproteins as Risk Factors for Coronary Heart Disease in Non-Insulin-Dependent Diabetes Mellitus, Ann. Med. 28, 341–345.
Allen, J.K., Young, D.R., Blumenthal, R.S., Moy, T.F., Yanek, L.R., Wilder, L., Becker, L.C., and Becker, D.M. (1996) Prevalence of Hypercholesterolemia Among Siblings of Persons with Premature Coronary Heart Disease. Application of the Second Adult Treatment Panel Guidelines, Arch. Int. Med. 156, 1654–1660.
Schaefer, E.J., Lichtenstein, A.H., Lamon-Fava, S., McNamara, J.R., and Ordovas, J.M. (1995) Lipoproteins, Nutrition, Aging, and Atherosclerosis, Am. J. Clin. Nutr. 61, 726S-740S.
Poulter, N.R. (1990) Major Risk Factors for Coronary Heart Disease in Hypertension: Implications for Management, J. Hum. Hypertens. 4, Suppl. 3:3–6.
Manninen, V., Elo, M.O., Frick, M.H., Haapa, K., Heinonen, O.P., Heinsalmi, P., Helo, P., Huttunen, J.K., Kaitaniemi, P., and Koskinen, P. (1988) Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study, JAMA 260, 641–651.
Castelli, W.P. (1996) Lipids, Risk Factors and Ischaemic Heart Disease, Atherosclerosis 124, S1-S9.
Wilson, P.W., Schaefer, E.J., Larson, M.G., and Ordovas, J.M. (1996) Apolipoprotein E Alleles and Risk of Coronary Disease. A Meta-analysis, Arterioscler, Thromb. Vasc. Biol. 16, 1250–1255.
Tiret, L., de Knijff, P., Menzel, H.J., Ehnholm, C., Nicaud, V., and Havekes, L.M. (1994) ApoE Polymorphism and Predisposition to Coronary Heart Disease in Youths of Different European Populations. The EARS Study. European Atherosclerosis Research Study, Arterioscler. Thromb. 14, 1617–1624.
Gomez-Coronado, D., Alvarez, J.J., Entrala, A., Olmos, J.M., Herrera, E., and Lasuncion, M.A. (1999) Apolipoprotein E Polymorphism in Men and Women from Spanish Population: Allele Frequencies and Influence on Plasma Lipids and Apolipoproteins, Atherosclerosis 147, 167–176.
Boer, J.M., Ehnholm, C., Menzel, H.J., Havekes, L.M., Rosseneu, M., O’Reilly, D.S., and Tiret, L. (1997) Interactions Between Lifestyle-Related Factors and the ApoE Polymorphism on Plasma Lipids and Apolipoproteins. The EARS Study. European Atherosclerosis Research Study, Arterioscler. Thromb. Vasc. Biol. 17, 1675–1681.
Kataoka, S., Robbins, D.C., Cowan, L.D., Go, O., Yeh, J.L., Devereux, R.B., Fabsitz, R.R., Lee, E.T., Welty, T.K., Thomas, K., and Howard, B.V. (1996) Apolipoprotein E Polymorphism in American Indians and Its Relation to Plasma Lipoproteins and Diabetes, The Strong Heart Study, Arterioscler. Thromb. Vasc. Biol. 16 918–925.
Murakami, K., Shimizu, M., Yamada, N., Ishibashi, S., Shimano, H., Yazaki, Y., and Akanuma, Y. (1993) Apolipoprotein E Polymorphism Is Associated with Plasma Cholesterol Response in a 7-Day Hospitalization Study for Metabolic and Dietary Control in NIDDM, Diabetes Care 16, 564–569.
Muscat, J.E., Harris, R.E., Haley, N.J., and Wynder, E.L. (1991) Cigarette Smoking and Plasma Cholesterol, Am. Heart J. 121 141–147.
Lee, K.S., Park, C.Y., Meng, K.H., Bush, A., Lee, S.H., Lee, W.C., Koo, J.W., and Chung, C.K. (1998) The Association of Cigarette Smoking and Alcohol Consumption with Other Cardiovascular Risk Factors in Men from Seoul, Korea, Ann. Epidemiol. 8, 31–38.
Butowski, P., and Winder, A. (1998) The Early Cardiovascular Toll of Cigarette Smoking in Dyslipidemic Patients in the United Kingdom, Eur. J. Med. Res. 3, 189–193.
Namekata, T., Moore, D.E., Suzuki, K., Mori, M., Knopp, R.H., Marcovina, S.M., Perrin, E.B., Hughes, D.A., Hatano, S., and Hayashi, C. (1997) Biological and Lifestyle Factors, and Lipid and Lipoprotein Levels Among Japanese Americans in Seattle and Japanese Men in Japan, Int. J. Epidemiol. 26, 1203–1213.
Vincelj, J., Sucic, M., Bergovec, M., Sokol, I., Mirat, J., Romic, Z., Lajtman, Z., Bergman-Markovic, B., and Bozikov, V. (1997) Serum Total, LDL, HDL Cholesterol and Triglycerides Related to Age, Gender and Cigarette Smoking in Patients with First Acute Myocardial Infarction, Coll. Antropol. 21, 517–524.
Ashakumary, L., and Vijayammal, P.L. (1997) Effect of Nicotine on Lipoprotein Metabolism in Rats, Lipids 32, 311–315.
Whitehead, T.P., Robinson, D., and Allaway, S.L. (1996) The Effects of Cigarette Smoking and Alcohol Consumption on Blood Lipids: A Dose-Related Study on Men, Ann. Clin. Biochem. 33, 99–106.
Craig, W.Y., Palomaki, G.E., and Haddow, J.E. (1989) Cigarette Smoking and Serum Lipid and Lipoprotein Concentrations: An Analysis of Published Data, Br. Med. J. 298, 784–788.
Freeman, D.J., Caslake, M.J., Griffin, B.A., Hinnie, J., Tan, C.E., Watson, T.D., Packard, C.J., and Shepherd, J. (1998) The Effect of Smoking on Post-Heparin Lipoprotein and Hepatic Lipase, Cholesteryl Ester Transfer Protein and Lecithin: Cholesterol Acyl Transferase Activities in Human Plasma, Eur. J. Clin. Invest. 28, 584–591.
Higgins, M., Province, M., Heiss, G., Eckfeldt, J., Ellison, R.C., Folsom, A.R., Rao, D.C., Sprafka, J.M., and Williams, R. (1996) NHLBI Family Heart Study: Objectives and Design, Am. J. Epidemiol. 143, 1219–1228.
Friedewald, W.T., Levy, R.I., and Fredrickson, D.S. (1972) Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge, Clin. Chem. 18, 499–502.
Warnick, G.R., Benderson, J., and Albers, J.J. (1982) Dextran Sulfate-Mg2+ Precipitation Procedure for Quantitation of High-Density-Lipoprotein Cholesterol, Clin. Chem. 28, 1379–1388.
Reymer, P.W. Groenemeyer, B.E., van de Burg, R., and Kastelein, J.J. (1995) Apolipoprotein E Genotyping on Agarose Gels, Clin. Chem. 41, 1046–1047.
Willett, W.C., Sampson, L., Stampfer, M.J., Rosner, B., Bain, C., Witschi, J., Hennekens, C.H., and Speizer, F.E. (1985) Reproducibility and Validity of a Semiquantitative Food Frequency Questionnaire, Am. J. Epidemiol. 122, 51–65.
Rimm, E.B., Giovannucci, E.L., Stampfer, M.J., Colditz, G.A., Litin, L.B., and Willett, W.C. (1992) Reproducibility and Validity of an Expanded Self-Administered Semiquantitative Food Frequency Questionnaire Among Male Health Professionals, Am. J. Epidemiol. 135, 1114–1126.
SAS/STAT User’s Guide (1989), version 6, 4th edn., Vol. 2, pp. 1071–1126, SAS Institute, Cary, NC.
Freeman, D.J., and Packard, C.J. (1995) Smoking and Plasma Lipoprotein Metabolism, Clin. Sci. 89, 333–342.
Brischetto, C.S., Connor, W.E., Connor, S.L., and Matarazzo, J.D. (1983) Plasma Lipid and Lipoprotein Profiles of Cigarette Smokers from Randomly Selected Families: Enhancement of Hyper-lipidemia and Depression of High-Density Lipoprotein, Am. J. Cardiol. 52, 675–680.
Tikannen, M.J., Huttunen, J.K., Ehnholm, C., and Pietinen, P. (1990) Apolipoprotein E4 Homozygosity Predisposes to Serum Cholesterol Elevation During High Fat Diet, Arteriosclerosis 10, 285–288.
Freeman, D.J., Griffin, B.A., Murray, E., Lindsay, G.M., Gaffney, D., Packard, C.J., and Shepherd, J. (1993) Smoking and Plasma Lipoproteins in Man: Effects on Low Density Lipoprotein Cholesterol Levels and High Density Lipoprotein Subfraction Distribution, Eur. J. Clin. Invest. 23, 630–640.
Moriguchi, E.H., Fusegawa, Y., Tamachi, H., and Goto, H. (1991) Effects of Smoking on HDL Subfractions in Myocardial Infarction Patients: Effects on Lecithin-Cholesterol Acyl Transferase and Hepatic Lipase, Clin. Chim. Acta. 195, 139–143.
Eliasson, B., Mero, N., Taskinen, M.R., and Smith, U. (1997) The Insulin Resistance Syndrome and Postprandial Lipid Intolerance in Smokers, Atherosclerosis 129, 79–88.
Packard, C.J., and Shepherd, J. (1993) Lipoprotein Metabolism in Lipase Deficient States: Studies in Primary and Secondary Hyperlipidemia, Biochem. Soc. Trans. 21, 503–506.
McCall, M.R., van den Berg, J.J., Kuypers, F.A., Tribble, D.L., Krauss, R.M., Knoff, L.J., and Forte, T.M. (1994) Modification of LCAT Activity and HDL Structure. New Links Between Cigarette Smoke and Coronary Heart Disease Risk, Arterioscler. Thromb. 14, 248–253.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Djoussé, L., Myers, R.H., Coon, H. et al. Smoking influences the association between apolipoprotein E and lipids: The national heart, lung, and blood institute family heart study. Lipids 35, 827–831 (2000). https://doi.org/10.1007/S11745-000-0591-1
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/S11745-000-0591-1